0.295
-0.02 (-7.52%)
| Previous Close | 0.319 |
| Volume | 67,906,112 |
| Price / Sales | 0.850 |
| Price / Book | 0.100 |
| 52 Weeks Range |
| Operating Margin (TTM) | -17,009.68% |
| Diluted EPS (TTM) | -1.17 |
| Quarterly Revenue Growth (YOY) | -89.30% |
| Total Debt/Equity (MRQ) | 4.03% |
| Current Ratio (MRQ) | 4.43 |
| Operating Cash Flow (TTM) | -29.41 M |
| Levered Free Cash Flow (TTM) | -16.91 M |
| Return on Assets (TTM) | -33.82% |
| Return on Equity (TTM) | -56.80% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Co-Diagnostics, Inc. | Mixed | Bearish |
AIStockmoo Score
| Value 35% | 0.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | 0.0 |
| Timing 35% | -0.5 |
| AI Technical info | NA |
| Technical Oscillators info | -2.5 |
| Technical Moving Averages info | 2.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.17 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -6.8% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | 0.5 |
| Final Score | -0.20 |
Select this tab to load the latest available analysis.
|
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 9.00% |
| % Held by Institutions | 17.44% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Private Advisory Group Llc | 30 Sep 2026 | 39,387 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |